Saltar al contenido
Merck
  • A Site-Specific Integrated Col2.3GFP Reporter Identifies Osteoblasts Within Mineralized Tissue Formed In Vivo by Human Embryonic Stem Cells.

A Site-Specific Integrated Col2.3GFP Reporter Identifies Osteoblasts Within Mineralized Tissue Formed In Vivo by Human Embryonic Stem Cells.

Stem cells translational medicine (2014-08-15)
Xiaonan Xin, Xi Jiang, Liping Wang, Mary Louise Stover, Shuning Zhan, Jianping Huang, A Jon Goldberg, Yongxing Liu, Liisa Kuhn, Ernst J Reichenberger, David W Rowe, Alexander C Lichtler
RESUMEN

The use of human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) for study and treatment of bone diseases or traumatic bone injuries requires efficient protocols to differentiate hESCs/iPSCs into cells with osteogenic potential and the ability to isolate differentiated osteoblasts for analysis. We have used zinc finger nuclease technology to deliver a construct containing the Col2.3 promoter driving GFPemerald to the AAVS1 site (referred to as a "safe harbor" site), in human embryonic stem cells (H9Zn2.3GFP), with the goal of marking the cells that have become differentiated osteoblasts. In teratomas formed using these cells, we identified green fluorescent protein (GFP)-positive cells specifically associated with in vivo bone formation. We also differentiated the cells into a mesenchymal stem cell population with osteogenic potential and implanted them into a mouse calvarial defect model. We observed GFP-positive cells associated with alizarin complexone-labeled newly formed bone surfaces. The cells were alkaline phosphatase-positive, and immunohistochemistry with human specific bone sialoprotein (BSP) antibody indicates that the GFP-positive cells are also associated with the human BSP-containing matrix, demonstrating that the Col2.3GFP construct marks cells in the osteoblast lineage. Single-cell cloning generated a 100% Col2.3GFP-positive cell population, as demonstrated by fluorescence in situ hybridization using a GFP probe. The karyotype was normal, and pluripotency was demonstrated by Tra1-60 immunostaining, pluripotent low density reverse transcription-polymerase chain reaction array and embryoid body formation. These cells will be useful to develop optimal osteogenic differentiation protocols and to isolate osteoblasts from normal and diseased iPSCs for analysis.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Quitosano, from shrimp shells, ≥75% (deacetylated)
Sigma-Aldrich
Anticuerpo anti-mitocondrial, superficie de mitocondrias intactas, clon 113-1, clone 113-1, Chemicon®, from mouse
Sigma-Aldrich
Anti-Bone Sialoprotein II Antibody, CT, clone ID1.2, clone ID1.2, Chemicon®, from mouse